Viewing Study NCT03763604


Ignite Creation Date: 2025-12-24 @ 7:59 PM
Ignite Modification Date: 2026-01-05 @ 5:54 PM
Study NCT ID: NCT03763604
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2024-12-16
First Post: 2018-12-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module